Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer

European Respiratory Journal

Volumn 45, Issue 4, 2015, Pages 1089-1097

  Ambrogi, Marcello C ^a   Fanucchi, Olivia ^b   Dini, Paolo ^b   Melfi, Franca ^b   Davini, Federico ^b   Lucchi, Marco ^b   Massimetti, Gabriele ^a   Mussi, Alfredo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CISANELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY; WEDGE RESECTION; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; LUNG NEOPLASMS; LUNG RESECTION; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SURVIVAL; TUMOR INVASION; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84926512010     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00188014     Document Type: Article

References (27)

1. Ginsberg RJ, Rubenstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 nonsmall cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60: 615-623.
2. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I nonsmall cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006; 82: 408-416.
3. Landreneau R, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) nonsmall cell lung cancer. J Thorac Cardiovasc Surg 1997; 113: 691-700.
4. Sienel W, Dango S, Kirschbaum A, et al. Sublobar resection in stage IA nonsmall cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Sur 2008; 33: 728-734.
5. Mery CM, Pappas AN, Bueno R, et al. Similar long-term survival of elderly patients with nonsmall cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005; 128: 237-245.
6. Steinke K, Sewell PE, Dupuy DE, et al. Pulmonary radiofrequency ablation: an international study survey. Anticancer Res 2004; 24: 339-343.
7. Simon CJ, Dupuy DE, Di Petrillo TA, et al. Pulmonary radiofrequency ablation: long term safety and efficacy in 153 patients. Radiology 2007; 243: 268-275.
8. Ambrogi MC, Fanucchi O, Cioni R, et al. Long-term results of radiofrequency ablation treatment of stage I nonsmall cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol 2011; 6: 2044-2051.
9. Common Terminology Criteria for Adverse Events version 4.03. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 2010.
10. www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0236. Date last updated November 2, 2011. Date last accessed: February 1, 2015.
11. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
12. Ambrogi MC, Fontanini G, Cioni R, et al. Biologic effects of radiofrequency thermal ablation on nonsmall cell lung cancer: results of a pilot study. J Thorac Cardiovasc Surg 2006; 131: 1002-1006.
13. Stainke K, Habicht JM, Thomsen S, et al. CT-guided radiofrequency ablation of a pulmonary metastasis followed by surgical resection. Cardiovasc Intervent Radiol 2002; 25: 543-546.
14. Yoo DC, Dupuy DE, Hillman SL, et al. Radiofrequency ablation of medically inoperable stage IA nonsmall cell lung cancer: are early posttreatment PET findings predictive for treatment outcome? AJR Am J Roentgenol 2011; 197: 334-340.
15. Crabtree T, Puri V, Timmerman R, et al. Treatment of stage I lung cancer in high-risk and inoperable patients: Comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg 2013; 145: 692-699.
16. Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I nonsmall cell lung cancer. J Thorac Cardiovasc Surg 2009; 137: 160-166.
17. Suh RD, Wallace AB, Sheehan RE, et al. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation - preliminary results. Radiology 2003; 229: 821-829.
18. Thanos L, Mylona S, Pomoni M, et al. Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors. Eur J Cardiothorac Surg 2006; 30: 797-800.
19. Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 2006; 241: 275-283.
20. Ricardi U, Frezza G, Filippi AR, et al. Stereotactic Ablative Radiotherapy for stage I histologically proven nonsmall cell lung cancer: an Italian multicenter observational study. Lung Cancer 2014; 84: 248-253.
21. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010; 28: 928-935.
22. Onishi H Araki T Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiisnstitutional study. Cancer 2004; 101: 1623-1631.
23. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage nonsmall-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009; 75: 677-682.
24. Dupuy D, Fernando H, Hillman S, et al. Radiofrequency Ablation of Stage 1A NSCLC in Medically Inoperable Patients: Results from ACOSOG Z4033 (Alliance), an NCI Funded Multicenter Trial. Chest 2013; 144: 86A-86A.
25. Lee H, Jin GY, Han YM, et al. Comparison of survival rate in primary nonsmall-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy. Cardiovasc Intervent Radiol 2012; 35: 343-350.
26. Kim SR, Han HJ, Park SJ, et al. Comparison between surgery and radiofrequency ablation for stage I nonsmall cell lung cancer. Eur J Radiol 2012; 8: 395-399.
27. Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I nonsmall cell lung cancer. J Am Coll Surg 2010; 211: 68-72.